Literature DB >> 18034310

Computational study on mechanism of G-quartet oligonucleotide T40214 selectively targeting Stat3.

Qiqing Zhu1, Naijie Jing.   

Abstract

The mounting evidences have shown that signal transducer and activator of transcription 3 (Stat3) is a critical target for cancer therapy. Recently, we developed a G-quartet oligonucleotide T40214 as a novel and potent Stat3 inhibitor. T40214 specifically inhibited DNA-binding activity of Stat3 and significantly suppressed the growth of many tumor xenografts in nude mice. To determine the mechanism of GQ-ODNs selectively targeting Stat3, we established a 3D model of complex T40214/p-Stat3 dimer based on experimental evidences. The binding site of T40214 within Stat3 dimer was determined by statistical docking analysis. The results indicated that T40214 strongly interacted within the region from residue E638 through E652 of Stat3 dimer. The binding model refined by Hex docking disclosed that T40214 binds to SH2 domain of Stat3 and forms H-bonds with residues Q643, Q644, N646, and N647, which are critical for the binding interaction. The 3D models also suggested that T40214 inhibits Stat3 activity through disrupting the binding interaction between Stat3 dimer and DNA duplex for transcription. Our computational studies provided a platform for future structure-based drug design of novel Stat3 inhibitors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18034310     DOI: 10.1007/s10822-007-9147-6

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  39 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  Protein docking using spherical polar Fourier correlations.

Authors:  D W Ritchie; G J Kemp
Journal:  Proteins       Date:  2000-05-01

Review 3.  Transcription factors as targets for cancer therapy.

Authors:  James E Darnell
Journal:  Nat Rev Cancer       Date:  2002-10       Impact factor: 60.716

4.  Targeting signal transducer and activator of transcription 3 with G-quartet oligonucleotides: a potential novel therapy for head and neck cancer.

Authors:  Naijie Jing; Qiqing Zhu; Ping Yuan; Yidong Li; Li Mao; David J Tweardy
Journal:  Mol Cancer Ther       Date:  2006-02       Impact factor: 6.261

5.  Structure of the unphosphorylated STAT5a dimer.

Authors:  Dante Neculai; Ana Mirela Neculai; Sophie Verrier; Kenneth Straub; Klaus Klumpp; Edith Pfitzner; Stefan Becker
Journal:  J Biol Chem       Date:  2005-09-28       Impact factor: 5.157

6.  Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells.

Authors:  R Catlett-Falcone; T H Landowski; M M Oshiro; J Turkson; A Levitzki; R Savino; G Ciliberto; L Moscinski; J L Fernández-Luna; G Nuñez; W S Dalton; R Jove
Journal:  Immunity       Date:  1999-01       Impact factor: 31.745

Review 7.  Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway.

Authors:  P C Heinrich; I Behrmann; G Müller-Newen; F Schaper; L Graeve
Journal:  Biochem J       Date:  1998-09-01       Impact factor: 3.857

Review 8.  Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins.

Authors:  J E Darnell; I M Kerr; G R Stark
Journal:  Science       Date:  1994-06-03       Impact factor: 47.728

9.  Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130.

Authors:  C Lütticken; U M Wegenka; J Yuan; J Buschmann; C Schindler; A Ziemiecki; A G Harpur; A F Wilks; K Yasukawa; T Taga
Journal:  Science       Date:  1994-01-07       Impact factor: 47.728

10.  Structure of an activated Dictyostelium STAT in its DNA-unbound form.

Authors:  Montserrat Soler-Lopez; Carlo Petosa; Masashi Fukuzawa; Raimond Ravelli; Jeffrey G Williams; Christoph W Müller
Journal:  Mol Cell       Date:  2004-03-26       Impact factor: 17.970

View more
  10 in total

Review 1.  Targeting STAT3 in cancer: how successful are we?

Authors:  Peibin Yue; James Turkson
Journal:  Expert Opin Investig Drugs       Date:  2009-01       Impact factor: 6.206

2.  Anti-arthritis effects of (E)-2,4-bis(p-hydroxyphenyl)-2-butenal are mediated by inhibition of the STAT3 pathway.

Authors:  Jung Ok Ban; Dae Hwan Kim; Hee Pom Lee; Chul Ju Hwang; Jung-Hyun Shim; Dae Joong Kim; Tae Myoung Kim; Heon-Sang Jeong; Seong Su Nah; Hanyong Chen; Zigang Dong; Young Wan Ham; Youngsoo Kim; Sang-Bae Han; Jin Tae Hong
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

3.  T40214/PEI complex: a potent therapeutics for prostate cancer that targets STAT3 signaling.

Authors:  Priya Weerasinghe; Yifei Li; Yongli Guan; Ruiwen Zhang; David J Tweardy; Naijie Jing
Journal:  Prostate       Date:  2008-09-15       Impact factor: 4.104

4.  Signal transducer and activator of transcription 3 (STAT3) regulates collagen-induced platelet aggregation independently of its transcription factor activity.

Authors:  Zhou Zhou; Francisca C Gushiken; Doug Bolgiano; Breia J Salsbery; Niloufar Aghakasiri; Naijie Jing; Xiaoping Wu; K Vinod Vijayan; Rolando E Rumbaut; Roberto Adachi; Jose A Lopez; Jing-Fei Dong
Journal:  Circulation       Date:  2012-12-24       Impact factor: 29.690

Review 5.  STAT3 inhibitors for cancer therapy: Have all roads been explored?

Authors:  Remi Fagard; Valeri Metelev; Inès Souissi; Fanny Baran-Marszak
Journal:  JAKSTAT       Date:  2013-01-01

6.  Novel synthetic (E)-2-methoxy-4-(3-(4-methoxyphenyl) prop-1-en-1-yl) phenol inhibits arthritis by targeting signal transducer and activator of transcription 3.

Authors:  Dong Ju Son; Dae Hwan Kim; Seong-Su Nah; Mi Hee Park; Hee Pom Lee; Sang Bae Han; Udumula Venkatareddy; Benjamin Gann; Kevin Rodriguez; Scott R Burt; Young Wan Ham; Yu Yeon Jung; Jin Tae Hong
Journal:  Sci Rep       Date:  2016-11-15       Impact factor: 4.379

7.  Chemical probes that competitively and selectively inhibit Stat3 activation.

Authors:  Xuejun Xu; Moses M Kasembeli; Xueqing Jiang; Benjamin J Tweardy; David J Tweardy
Journal:  PLoS One       Date:  2009-03-10       Impact factor: 3.240

8.  Transcription Factor STAT3 as a Novel Molecular Target for Cancer Prevention.

Authors:  Ailian Xiong; Zhengduo Yang; Yicheng Shen; Jia Zhou; Qiang Shen
Journal:  Cancers (Basel)       Date:  2014-04-16       Impact factor: 6.639

Review 9.  Targeting STAT3 in Cancer with Nucleotide Therapeutics.

Authors:  Yue-Ting K Lau; Malini Ramaiyer; Daniel E Johnson; Jennifer R Grandis
Journal:  Cancers (Basel)       Date:  2019-10-29       Impact factor: 6.639

Review 10.  Manipulation of JAK/STAT Signalling by High-Risk HPVs: Potential Therapeutic Targets for HPV-Associated Malignancies.

Authors:  Ethan L Morgan; Andrew Macdonald
Journal:  Viruses       Date:  2020-09-03       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.